title: Glutamine targeting inhibits systemic metastasis in the VM-M3 murine tumor model.
abstract: Metastatic cancer is a major cause of morbidity and mortality. Current therapeutic options consist of chemotherapy, radiation or targeted therapies. However, these therapies are often toxic, effective over a small range of cancer types or result in drug resistance. Therefore, a more global, less toxic strategy for the management of metastatic cancer is required. Although most cancers display increased glucose metabolism, glutamine is also a major energy substrate for many cancers. We evaluated the antimetastatic potential of 6-diazo-5-oxo-L-norleucine (DON), a glutamine analog, using the new VM mouse model of systemic metastasis. We found that primary tumor growth was ∼20-fold less in DON-treated mice than in untreated control mice. We also found that DON treatment inhibited metastasis to liver, lung and kidney as detected by bioluminescence imaging and histology. Our findings provide proof of concept that metabolic therapies targeting glutamine metabolism can manage systemic metastatic cancer.
authors.affiliation: Department of Biology, Boston College, Chestnut Hill, MA 02467, USA.
authors.forename: Laura M
authors.initials: LM
authors.lastname: Shelton
authors.forename: Leanne C
authors.initials: LC
authors.lastname: Huysentruyt
authors.forename: Thomas N
authors.initials: TN
authors.lastname: Seyfried
mesh_terms: D000818:Animals; D000964:Antimetabolites, Antineoplastic / Q000494:pharmacology*; D001786:Blood Glucose / Q000378:metabolism; D001835:Body Weight; D001932:Brain Neoplasms / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D031204:Caloric Restriction; D048708:Cell Growth Processes / Q000187:drug effects; D045744:Cell Line, Tumor; D054022:Cerebrum / Q000378:metabolism / Q000473:pathology; D003980:Diazooxonorleucine / Q000494:pharmacology*; D016503:Drug Delivery Systems; D005260:Female; D005947:Glucose / Q000172:deficiency / Q000378:metabolism; D005973:Glutamine / Q000172:deficiency / Q000378:metabolism*; D008297:Male; D051379:Mice; D009362:Neoplasm Metastasis
chemical_list: D000964:Antimetabolites, Antineoplastic; D001786:Blood Glucose; D003980:Diazooxonorleucine; D005973:Glutamine; D005947:Glucose
references.citation: Cancer Res. 1959 May;19(4):388-92
references.pmid: 13652122
references.citation: J Biol Chem. 1979 Apr 25;254(8):2669-76
references.pmid: 429309
references.citation: Curr Treat Options Oncol. 2008 Dec;9(4-6):326-42
references.pmid: 19225891
references.citation: Clin Cancer Res. 2004 Feb 1;10(3):1150-9
references.pmid: 14871995
references.citation: Cancer Lett. 2007 Dec 18;258(2):155-64
references.pmid: 17977647
references.citation: Arch Pathol Lab Med. 1980 Dec;104(12):651-3
references.pmid: 6893661
references.citation: Cell Biochem Funct. 2003 Mar;21(1):1-9
references.pmid: 12579515
references.citation: J Biol Chem. 1979 Apr 25;254(8):2835-8
references.pmid: 429321
references.citation: Free Radic Biol Med. 2000 Nov 1;29(9):913-23
references.pmid: 11063916
references.citation: Tokushima J Exp Med. 1992 Jun;39(1-2):69-76
references.pmid: 1412455
references.citation: Cancer Res. 1994 Apr 1;54(7):1690-4
references.pmid: 8137283
references.citation: J Cutan Pathol. 2009 Jan;36(1):64-6
references.pmid: 18715256
references.citation: Cancer Res. 2009 Oct 15;69(20):7986-93
references.pmid: 19826036
references.citation: Int J Cancer. 2010 Jan 1;126(1):65-72
references.pmid: 19536778
references.citation: Nat Rev Cancer. 2006 Jun;6(6):449-58
references.pmid: 16723991
references.citation: Transplantation. 2007 Jul 27;84(2):272-4
references.pmid: 17667822
references.citation: Cancer. 1985 Oct 1;56(7 Suppl):1778-82
references.pmid: 4027909
references.citation: Cancer Lett. 1998 Nov 13;133(1):95-9
references.pmid: 9929166
references.citation: Proc Natl Acad Sci U S A. 2007 Dec 4;104(49):19345-50
references.pmid: 18032601
references.citation: Cell Cycle. 2008 Jul 15;7(14):2083-9
references.pmid: 18635953
references.citation: Br J Cancer. 2006 Mar 13;94(5):614-9
references.pmid: 16465192
references.citation: Oral Oncol. 2009 Feb;45(2):148-55
references.pmid: 18635390
references.citation: Cell Biochem Funct. 1996 Mar;14(1):1-10
references.pmid: 8907248
references.citation: Clin Cancer Res. 2004 Aug 15;10(16):5622-9
references.pmid: 15328205
references.citation: Physiol Genomics. 2006 Nov 27;27(3):187-200
references.pmid: 16882887
references.citation: Clin Cancer Res. 2008 Dec 1;14(23):7751-62
references.pmid: 19047102
references.citation: Br J Cancer. 2002 May 20;86(10):1615-21
references.pmid: 12085212
references.citation: Int J Cancer. 2008 Jul 1;123(1):73-84
references.pmid: 18398829
references.citation: Nutr Metab (Lond). 2008 Nov 25;5:33
references.pmid: 19032781
references.citation: Annu Rev Pathol. 2008;3:221-47
references.pmid: 18233952
references.citation: Scand J Haematol. 1973;11(3):253-6
references.pmid: 4128872
references.citation: Adv Pharmacol Chemother. 1970;8:57-120
references.pmid: 4400179
references.citation: Nutr Metab (Lond). 2010 Jan 27;7:7
references.pmid: 20181022
references.citation: J Biol Chem. 1990 Jul 5;265(19):11377-81
references.pmid: 2358467
references.citation: Mol Cancer Ther. 2009 Jan;8(1):10-6
references.pmid: 19139108
references.citation: Proc R Soc Lond B Biol Sci. 1972 Jul 25;182(1066):25-35
references.pmid: 4403084
references.citation: J Nutr. 2001 Sep;131(9 Suppl):2475S-85S; discussion 2486S-7S
references.pmid: 11533296
references.citation: Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14878-83
references.pmid: 19706488
references.citation: J Clin Neurosci. 2005 May;12(4):379-82
references.pmid: 15925766
references.citation: Cancer. 1957 Nov-Dec;10(6):1138-50
references.pmid: 13489662
references.citation: N Engl J Med. 2006 Dec 28;355(26):2783-5
references.pmid: 17192546
references.citation: Cancer Res. 2006 Apr 1;66(7):3629-38
references.pmid: 16585188
references.citation: Am J Physiol. 1998 May;274(5):E801-7
references.pmid: 9612237
references.citation: Int J Biochem. 1993 Dec;25(12):1749-55
references.pmid: 8138012
references.citation: J Neurooncol. 1998 Apr;37(2):97-108
references.pmid: 9524087
references.citation: Int J Radiat Oncol Biol Phys. 2007 Sep 1;69(1):214-20
references.pmid: 17707275
references.citation: Am J Physiol. 1986 Jul;251(1 Pt 1):E117-26
references.pmid: 2873746
references.citation: Nat Rev Cancer. 2002 Aug;2(8):563-72
references.pmid: 12154349
references.citation: Br J Neurosurg. 2005 Aug;19(4):348-51
references.pmid: 16455543
references.citation: Science. 2009 Jul 31;325(5940):612-6
references.pmid: 19644120
references.citation: Cancer Res. 1979 Aug;39(8):3220-4
references.pmid: 572261
references.citation: Cytopathology. 2006 Oct;17(5):304-5
references.pmid: 16961662
references.citation: Br J Cancer. 2001 Apr 20;84(8):1107-14
references.pmid: 11308262
references.citation: Prostate. 2007 Aug 1;67(11):1211-8
references.pmid: 17525933
references.citation: Int J Cancer. 2002 Oct 10;101(5):496-9
references.pmid: 12216080
references.citation: Neuro Oncol. 2005 Apr;7(2):177-82
references.pmid: 15831235
references.citation: J Nutr. 2001 Sep;131(9 Suppl):2539S-42S; discussion 2550S-1S
references.pmid: 11533309